张林琳, 贺大林, 李翔, 李磊, 罗勇, 于琳华, Hsieh JT. 柯萨奇-腺病毒受体在肾癌组织中的表达及意义[J]. 中国肿瘤临床, 2005, 32(20): 1141-1143. DOI: 10.3969/j.issn.1000-8179.2005.20.001
引用本文: 张林琳, 贺大林, 李翔, 李磊, 罗勇, 于琳华, Hsieh JT. 柯萨奇-腺病毒受体在肾癌组织中的表达及意义[J]. 中国肿瘤临床, 2005, 32(20): 1141-1143. DOI: 10.3969/j.issn.1000-8179.2005.20.001
Zhang Linlin, He Dalin, Li Xiang, Li Lei, Luo Yong, Yu Linhua, Hsieh JT. The Expression and Significance of Coxsackie and Adenovirus Receptor in Renal Cell Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 32(20): 1141-1143. DOI: 10.3969/j.issn.1000-8179.2005.20.001
Citation: Zhang Linlin, He Dalin, Li Xiang, Li Lei, Luo Yong, Yu Linhua, Hsieh JT. The Expression and Significance of Coxsackie and Adenovirus Receptor in Renal Cell Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 32(20): 1141-1143. DOI: 10.3969/j.issn.1000-8179.2005.20.001

柯萨奇-腺病毒受体在肾癌组织中的表达及意义

The Expression and Significance of Coxsackie and Adenovirus Receptor in Renal Cell Carcinoma

  • 摘要: 目的: 研究柯萨奇-腺病毒受体(CAR)在肾癌组织中的表达及意义。 方法: 应用免疫组化SP法检测12例癌旁正常肾组织和48例肾细胞癌组织中CAR的表达。 结果: 12例正常肾组织全部表达CAR,48例肾细胞癌组织中31例无CAR表达。不同分级CAR表达率分别为Ⅰ级54.5%(12/22)、Ⅱ级23.5%(4/17)、Ⅲ级11.1%(1/9);不同分期CAR表达率分别为Ⅰ期57.9%(11/19)、Ⅱ期30.8%(4/13)、Ⅲ期18.2%(2/11)、Ⅳ期0(0/5)。 结论: 在多数肾细胞癌组织中CAR基因表达丧失;CAR表达变化与肾癌的分级、分期相关,可以作为肾癌分化、转移的重要生物学指标。

     

    Abstract: Objective :To investigate the expression of the coxsackie and adenovirus receptor (CAR) in renal cell carcinoma and its relationship with the biological behaviors. Methods :The method of mmunohistochemistry SP was used to detect the expression of CAR in 48 cases with renal cell carcinoma tissue and 12 cases with paraneoplastic normal renal tissue (about 2 cm away from tumorous tissue). Results :The positive rate of CAR was 100% in the 12-case group and 35.4% in the 48-c asegroup (31 cases). The difference of CAR expression between the two groups was significant (P<0.05). The positive rate of CAR in I grade (22 cases), II grade (17 cases) and III grade (9 cases) was 54.5%, 23.5 % and 11.1 %,respectively, and there was a negative correlation between CAR expression andgrading (P<0.05). Meanwhile, the the positive rate in stage I with 19 cases, stage II with 13, stage III with 11 and stage IV with 5 was 57.9%,30.8 %,18.2% and 0.0%,respectively. So, there was a relationship between the CAR expression and the staging (P<0.05). Conclusions :The loss of CAR geneexpression occurs in most of the renal cell carcinoma. The change in the level of CAR expression correlates with the grading and staging of renal cell carcinoma and can be a sensitive predictor of differennation, and metastasis of renal carcinoma.

     

/

返回文章
返回